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ALGORITMO PARA EL DIAGNÓSTICO PRECOZ
DE LA DEFICIENCIA DE VITAMINA B12 
EN ANCIANOS
Resumen
Introducción: Los mayores son una población que
presenta un riesgo importante de desarrollar una deficiencia
de vitamina B
12
, pero las concentraciones de cobalamina en
suero no reflejan necesariamente un estado abnormal en el
estado de B
12 
. Existen biomarcadores asociados a la vitamina
B
12
: el ácido metilmalónico no está disponible en todos los
laboratorios, la holotranscobalamina es poco sensible y la
homocisteína presenta una baja especificidad. El objetivo del
presente estudio es establecer un algoritmo de diagnóstico
mediante el uso de una combinación de estos biomarcadores
en lugar de la medición de uno sólo de ellos.
Métodos: Se comparó la eficacia diagnóstica de estos
marcadores para la detección de deficiencia de vitamina B
12
en una población (n = 218) de ancianos institucionalizados
(edad media 80 años). Los parámetros bioquímicos, hema-
tológicos y morfológicos fueron utilizados para clasificar a
los sujetos con o sin deficiencia de vitamina B
12
.
Resultados: Se establecieron las curvas ROC (Receiver
Operating Curves) para determinar la eficacia diagnóstica
de cada parámetro, tomado individualmente. El folato sérico
tenía la mayor área bajo la curva (0,87) y la homocisteína la
más baja (0,67). Se observó que la mejor especificidad la
presentaba el folato eritrocitario y el ácido metilmalónico
(100% para ambos), pero sus sensibilidades eran muy bajas
(17% y 53%, respectivamente). Y se observó que la sensibi-
lidad más alta la presentaba la homocisteína (81%) y el folato
sérico (74%), pero en contrapartida una especificidad baja.
Cuando se combinaron estos marcadores, iniciando las
determinaciones con el folato sérco y eritrocitario, seguido
por holotranscobalamina y terminando por las mediciones
de ácido metilmalónico, la sensibilidad y especificidad global
del algoritmo fueron 100% y 90%, respectivamente.
Conclusión: El algoritmo propuesto, que combina la
determinación de folato sérico y eritrocitario, holotransco-
balamina y ácido metilmalónico, sin necesidad de evaluar la
vitamina B
12
y la homocisteína, es una alternativa útil para la
detección de un estado abnormal del estado de vitamina B
12
en una población de ancianos institucionalizados.
(Nutr Hosp. 2013;28:1447-1452)
DOI:10.3305/nh.2013.28.5.6821
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Abstract
Background: The elderly population is particularly at
risk for developing vitamin B
12
-deficiency. Serum cobal-
amin does not necessarily reflect a normal B
12 
status. The
determination of methylmalonic acid is not available in
all laboratories. Issues of sensitivity for holotranscobal-
amin and the low specificity of total homocysteine limit
their utility. The aim of the present study is to establish a
diagnostic algorithm by using a combination of these
markers in place of a single measurement. 
Methods: We compared the diagnostic efficiency of
these markers for detection of vitamin B
12
deficiency in a
population (n = 218) of institutionalized elderly (median
age 80 years). Biochemical, haematological and morpho-




Results: In receiver operating curves characteristics
for detection on vitamin B
12 
deficiency using single
measurements, serum folate has the greatest area under
the curve (0.87) and homocysteine the lowest (0.67). The
best specificity was observed for erythrocyte folate and
methylmalonic acid (100% for both) but their sensitivity
was very low (17% and 53%, respectively). The highest
sensitivity was observed for homocysteine (81%) and
serum folate (74%). When we combined these markers,
starting with serum and erythrocyte folate, followed by
holotranscobalamin and ending by methylmalonic acid
measurements, the overall sensitivity and specificity of
the algorithm were 100% and 90%, respectively. 
Conclusion: The proposed algorithm, which combines
erythrocyte folate, serum folate, holotranscobalamin and
methylmalonic acid, but eliminate B
12
and tHcy measure-
ments, is a useful alternative for vitamin B
12 
deficiency
screening in an elderly institutionalized cohort.
(Nutr Hosp. 2013;28:1447-1452)
DOI:10.3305/nh.2013.28.5.6821
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Introduction
In developed countries, clinical vitamin deficiency
has mostly disappeared and only affects marginal
population groups. May be the only exception is for
vitamin B
12
, which clinical deficiency, the mega-
loblastic anemia, affects around 20% of the elderly
people in developed countries.1 Also at risk for clin-
ical vitamin B
12
deficiency are vegetarians, the more
strict vegetarians the higher the risk,2 people
suffering from gastritis and chronic consumers of
medication for this pathology, like H2 pump
inhibitors.3,4 Subclinical deficiency is quite more
prevalent, especially in the elderly.5-9 In the literature
there are data ranging from 6 to 40%, but as there is
no accepted method for a valid diagnosis of subclin-
ical vitamin B
12
deficiency, these data have to be
taken with caution. In the general population, the
most prevalent vitamin deficiency is for folate that
affects both sexes and all age groups.10,11 This means
that in the elderly people, folate and vitamin B
12
defi-
ciency come together. In fact, the combined folate/
vitamin B
12
deficiency was supposed to be present in
up to 63% of the healthy elderly subjects and up to
83% in elderly hospitalized patients.12 As both
vitamin deficiencies lead to the development of
megaloblastic anemia and the clinical diagnosis
based on the identification of the hypersegmentation
of the nucleus of neutrophiles is common to both
deficiencies, it is not possible to differentiate by this
method if there is an isolated vitamin B
12
or isolated
folate deficiency or a combined deficiency, besides
that it appears at a later stage.13 But early diagnosis is
decisive, as neurologic symptoms due to vitamin B
12
deficiency at an advanced state are irreversible.14,15
Therefore, the scientific community is searching for
a better diagnostic method, which could be used in
the routine clinical laboratory, considering also
economical aspects. Normal serum cobalamin (B
12
)
does not necessarily reflect a normal B
12 
status.
Methylmalonic acid (MMA) has been also proposed
as an alternative diagnostic method for vitamin B
12
deficiency.16 A relatively novel marker, Holo-
transcobalamin (HoloTC), has been presented to
afford superior diagnostic specificity because it
constitutes the biologically functional vitamin B
12
fraction.17,18 Total homocysteine (tHcy) has been
cited as a marker for blood B vitamin levels.16 Argu-
ments will be discussed further in this article, but all
in all, it seems that no single parameter will allow
early accurate identification of vitamin B
12
defi-
ciency.19 Therefore, the main objective of our study
was to establish a diagnostic scheme in order to try to
facilitate early diagnosis and to differentiate between





deficiency. For this aim, we have used several B
12
-
related parameters measured in Spanish institutional-






This study is part of a broader study that aims to estab-
lish the vitamin B status of Spanish institutionalized
elderly, with special regard to vitamin B
12
and folate in
association with homocysteine. It has been supported by
a grant from the Fondo de Investigación Sanitaria of the
Instituto de Salud Carlos III (Spanish Ministry of Health,
FIS PI021830). Briefly, this study includes nutritional
assessment by means of the Mini Nutritional Assess-
ment,20 cognitive analysis by means of the Mini Mental
State21 and haematological and biochemical data. For this
work, from all the analysed variables in the blood, those
which are related directly to B
12
and folate metabolism
were selected, based on clinical criteria and correlation
coefficients9: B
12
, HoloTC, tHcy, serum folate, erythro-
cyte folate, and MMA. 
Study population
Two-hundred and eighteen elderly (82 males, 136
females) with a median age (percentile 5th-95th range)
of 80 years (65-90 years) living in an Elderly s Home in
Granada, Spain, were recruited for the study. The resi-
dents who took part in the study were all elderly living
at the residence. They were not taking any vitamin
supplement. Anamnesis and blood sampling were
included in the biannual medical review that is
performed in all the elderly living in the residence.
There were no exclusion criteria. None of the volun-
teers presented any problem that would have justified
their exclusion from the study. The study was approved
by the Human Research Review Committee of the
University of Granada, School of Medicine. The study
has been performed following the ethic norms of the
Declaration of Helsinki (revision of Edinburgh 2000),
Convention of Oviedo, the Good Clinical Practice of
the CEE (document 111/3976/88 July 1990) and the
Spanish legislation about clinical research in humans
(Real Decreto 561/1993 sobre ensayos clínicos).
Informed written consent was obtained from subjects
and/or their legal representatives.
Analytical methods
After an overnight fast, blood samples were drawn
between 8:00 and 10:00 h in the morning. Following
venipuncture, 3 ml of EDTA-treated blood was
analysed within an hour. Two 8 ml vacutainers with gel
for serum were put on ice immediately and centrifuged
within one hour at 2000 x g and 4° C for 10 min.
Following centrifugation they were aliquoted and
immediately frozen at -80º C. 
Hypersegmentation of the neutrophylic granu-
lozytes was analysed as lobe average and according to
1448 Gonzalo Palacios et al.Nutr Hosp. 2013;28(5):1447-1452
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the rule of five.21 tHcy was measured using a fluores-
cence polarisation immunoassay and serum folate,
erythrocyte folate, and B
12
were determined by
microparticle enzyme immunoassay by using IMx
analyzer (Abbott Laboratories, Abbott Park, IL).
HoloTC levels were measured by radioimmunoassay
provided by Axis-Shield (Oslo, Norway). MMA was
analysed by gas chromatography-mass spectrometry.
Statistical methods
No statistical significant differences (p > 0.05) were
found between sexes; therefore, all data for both men
and women were analysed together. As not all the vari-
ables followed a normal distribution, after using the
Kolmogorov-Smirnov test, natural log-transformed
data were used for calculating Pearson’s correlations
coefficients to examine linear associations between the
different markers. 
To determine the single relative efficiency of SCbl,
HoloTC, tHcy, serum folate, erythrocyte folate and
MMA to discriminate among individuals with vitamin
B
12
deficiency and the others individuals, ROC curves
were constructed and areas under the curve (AUCs)
compared. Subjects with or without vitamin B
12
defi-
ciency were categorized by using biochemical (SCbl,
tHcy), haematological (RBC count, haemoglobin,
hematocrit, MCV, MCH, MCHC, reticulocytes count)
and morphological (lobe average, rule of five) data.
Cutoff values for each metabolite were based on
literature reports or standard clinical concentrations.
These cutoff values were as follows: B
12
≤ 148 pmol/l
(standard clinical value), HoloTC ≤ 35 pmol/l17, tHcy >
13 µmol/l17, serum folate ≤ 7 µg/l (standard clinical
value), erythrocyte folate ≤ 175 µg/l (standard clinical
value) and MMA ≥ 300 nmol/l.23
A hierarchical step-by-step classification model was
developed by using different combinations of these
biomarkers. In order to decide which of these combina-
tions presented the best diagnostic efficiency, sensi-
tivity and specificity for detecting individuals with
vitamin deficiency were determined for the algorithms
proposed by using the cutoff values cited above. The
diagnostic outcomes of these algorithms were divided





-folate deficiency, 3) isolated folate deficiency and
4) normal. ANOVA analysis was performed to deter-
mine if there were significant differences for each of
the biomarkers in the different outcomes.
Sample size for each variable was not equal because
sufficient volumes of blood were not available from all
participants for each assay (table I). Statistical analyses
were made with data from individuals having available
measurements for all variables used in any particular
analyses and they were performed using SPSS for
Windows (ver.19.0, SPSS Inc) and MedCalc (ver.
11.6.1.0, MedCalc Software bvba). Statistical signifi-
cance was defined for all analyses as P < 0.05. 
Results
Table I summarizes the population characteristics. A
large proportion (63.6%) of the population had
increased tHcy levels (> 13 µmol/l). The prevalence for
serum folate deficiency (≤ 7 µg/l) was present in 62.4%
of individuals, although only 14.2% had erythrocyte
folate levels below the normal range (≤ 175 µg/l).
Increased level of MMA (≥ 300 nmol/l) was present in
48.8% of participants and 23.8% had holoTC levels
below normality (≤ 35 pmol/l). Subnormal level of B
12
(≤ 148 pmol/l) was present in 17.4% of population. The







-folate and isolated folate
deficiencies) determined by biochemical, haematolog-
ical and morphological data, was 83.3%.
The strongest positive linear associations were
observed between B
12
and holoTC (correlation coeffi-
cient: r = 0.65, P < 0.001), B
12
and erythrocyte folate
(r = 0.33, p < 0.001), erythrocyte folate and serum
folate (r = 0.39, P < 0.001), holoTC and MMA (r =
0.31, P < 0.001). Higher inverse correlations were
obtained for MMA with B
12
(r = -0.32, P < 0.001) and
serum folate with tHcy (r = -0.29, P < 0.001).
To establish the best variable to start the algorithm,
we constructed ROC curves that indicated the capacity
of each measurement to discriminate between individ-
uals with or without vitamin deficiency. The AUC (CI)
of the ROC curve for serum folate [0.87 (0.82-0.91)]






Variable n Median (p5th-p95th) Percent abnormal (cutoff value)
Age, years 218 80 (65-90)
B
12
, pmol/l 216 231 (96-549) 17.4 (≤ 148)
Serum folate, μg/l 218 6.1 (2.8-15) 62.4 (≤ 7)
Erithrocyte folate, μg/l 218 275 (111-696) 14.2 (≤ 175)
Holo-TC, pmol/ml 214 (13-210) 23.8 (≤ 35)
MMA, nmol/l 205 281 (100-864) 46.8 (≥ 300)
tHcy, μmol/l 217 15.8 (9.1-26.3) 63.6 (> 13)
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indicated that this variable presented the best diag-
nostic efficiency (table II). The cutoff value for serum
folate (≤ 7 µg/l) had a sensitivity and specificity of 74%
and 94%, respectively. The AUC (CI) for erythrocyte
folate was the second larger area [0.78 (0.72-0.83)] and
the cutoff value (≤ 175 µg/L) had a sensitivity (17%)
much lower than the cutoff for serum folate, whereas a
better specificity (100%). As both serum and erythro-
cyte folate presented the highest discrimination
capacity we decide to start the algorithm A by deter-
mining folate status first (fig. 1). If the cutoff values for
serum folate and erythrocyte folate were used together
1450 Gonzalo Palacios et al.Nutr Hosp. 2013;28(5):1447-1452
Table II
ROC curves characteristics
Variable AUC (CI)1 Cutoff value Sensitivity Specificity
B
12
, pmol/l 0.69 (0.62-0.75) ≤ 148 0.20 0.94
Serum folate, ng/ml 0.87 (0.82-0.91) ≤ 7 0.74 0.94
Erithrocyte folate, ng/ml 0.78 (0.72-9.83) ≤ 175 0.17 1.00
Holo-TC, pmol/ml 0.75 (0.67-0.81) ≤ 35 0.44 0.94
MMA, nmol/l 0.77 (0.72-0.84) ≥ 300 0.53 1.00
tHcy, μmol/l 0.67 (0.61-0.74) > 13 0.81 0.30
1Area under the curve and 95% confidence interval.
Fig. 1.—Algoritms A and B
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Units: Serum folate μg/L, erithrocyte folate μg/L, HoloTC pmol/mL, MMA nmol/L  
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such that all individuals with low values for one or both
of the measurement were combined, the sensitivity and
specificity were 78% and 94%, respectively (table III). 
AUCs for Holo-TC and MMA were similar (0.75 and
0.77, respectively) and they were higher than for the other
two measurements not used yet, B
12
and tHcy (0.69 and
0.67 respectively). Then we could use as a second
measurement for the algorithm A both variables, holoTC
or MMA. Because MMA analysis is expensive and MS-
GC method is not available in most laboratories, whereas
holoTC measurement can be carried out by using auto-
mated immunoassays, this last variable was preferred for
the second step of algorithm A. HoloTC was measured
on all the individuals, having or not normal folate status.
If we combined the three variables (serum folate, erythro-
cyte folate and holoTC) the sensitivity reached 91%,
while the specificity was slightly lower (91%) than
measuring only serum and erythrocyte folate (Table 3).
MMA was measured for the third and last step of algo-
rithm A. The final sensitivity and specificity were 100%
and 90%, respectively, and algorithm A included 6
possible outcomes: two diagnose an isolated B
12
defi-
ciency, two a combined deficiency, one an isolated folate
deficiency and one normal status. 
Algorithm B (fig. 1) represents a slight modification
of algorithm A due to a change in the classification of
individuals with or without holoTC deficiency.
HoloTC measurements were divided in three groups:
probable holoTC deficiency (< 30 pmol/l), possible
holoTC deficiency (grey zone, between 30 and 40
pmol/l) and holoTC deficiency unlikely (> 40 pmol/l).
Using algorithm B, MMA measurements would be
carried out only for individuals with holoTC levels into
the grey zone and this diagnostic strategy presented a
sensitivity slightly lower than for algorithm A (91%
and 100%) but a similar specificity (91% and 90%.
Algorithm B included 8 possible outcomes: two diag-
nose an isolated B
12
deficiency, two a combined defi-
ciency, two an isolated folate deficiency and two a
normal status. 
Significant differences were observed for all





. HoloTC levels were lowest and MMA
levels highest in the combined deficiency group, serum
folate was lowest in the isolated folate deficiency group,
whereas erythrocyte folate was lowest in the combined
deficiency group. tHcy was highest in the combined
deficiency group. The only difference observed between
algorithm A and B was for erythrocyte folate levels
which were higher in isolated B
12
deficiency in algorithm
A than in algorithm B. In the rest of the outcomes, levels
and patterns were very similar. 
Discussion
As has been stated before, especially in the elderly,
there is a need to detect at the initial phase vitamin B
12
deficiency, because they are at a greater risk for func-
tional B
12
deficiency. The clinical presentation of
vitamin B
12
deficiency varies considerably and rarely
includes all the classic features, such as macrocytic
anemia, peripheral neuropathy and sub-acute combined
degeneration of the spinal cord24. More typically, vitamin
B
12
deficiency presents as non-specific symptoms
fatigue, lassitude, malaise, vertigo, and cognitive
impairment that could be attributed to old age and
should be avoided by means of early detection. More-
over, the clinical severity of vitamin B
12
deficiency is
often unrelated to B
12
concentrations.19,25 This has been
demonstrated in our study by the small AUC (0.69) for
B
12 
ROC curve and its low sensitivity (20%) when
using a cutoff of 148 pmol/l as the only diagnostic
criterion. This means, that functional deficiency occurs
even in people whose B
12
levels are in the reference
range. Concerns about the limitations of standard
vitamin B
12
assays have been stated before.17,24,26
When using in single the rest of variables as the
screen for vitamin B
12
deficiency, the ROC curve for
serum folate showed the larger AUC (0.87) with a good
specificity (94%) but the sensitivity reached only 74%.
The use of only erythrocyte folate measurement did not
appear to be useful to discriminate individuals with
inadequate vitamin B
12
status due to its very low sensi-
tivity (17%). When combining both folate measure-
ments, specificity remained high (94%) but sensitivity
(78%) increased only slightly compared with the sensi-
tivity (74%) of serum folate used alone. 
HoloTC has been proposed in the literature as a more
sensitive marker.25-27 However, measurement of HoloTC
alone for vitamin B
12
deficiency showed in our study a
poor sensitivity (44%) that makes it unsuitable for
screening. In order to increase the overall sensitivity
detecting abnormal vitamin B
12
status and preserving a
good specificity, we combined both folate measure-
ments with HoloTC values, obtaining a sensitivity and
specificity of 91% for both (table III). Mean HoloTC
levels are below 35 pmol/l in the isolated B
12
and in the
combined deficiency group in algorithm B. In fact, we
found a strong correlation (r = 0.656; p < 0.001)
between HoloTC and SCbl. 
The clinical-economical advantage of algorithm B is
that less MMA measurements have to be performed.
MMA analysis is very expensive and the MS-GC
method is complicated and not possible in the routine
laboratory. There are several other physiological/
pathological conditions where MMA is elevated, not
only in B
12
deficiency.25 Furthermore, in the 93 subjects





Sensitivity and specificity for algorithm A
Measurement combination Sensitivity Specificity
Serum folata 0.74 0.94
Serum folate, erythrocyte folate 0.78 0.94
Serum folate, erythrocyte folate, Holo-TC 0.91 0.91
Serum folate, erythrocyte folate, Holo-TC, MMA 1.00 0.90
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with MMA ≥ 300 pmol/l, mean B
12
levels were 234.05 ±
168 pmol/l and mean HoloTC levels were 54.63 ± 46.3
pmol/l. The advantage of HoloTC is that is specific for
cobalamin metabolism and the analysis can be
performed in the routine laboratory. Mean tHcy levels
were 17.9 ± 6.66 µmol/l. MMA and HoloTC have a
highly significant correlation (r = 0.500; p < 0.001).
The advantage of the diagnostic schemes proposed
in this paper is that they allow not only to identify
subclinical deficiencies, but also to distinguish
between isolated B
12
, isolated folate or combined
B
12
/folate deficiency. This diagnosis is important for
the therapeutic treatment. The serum concentrations of
the vitamins taken by their own can not give such
specific information. On the other hand, as adequate
cut-off points for blood parameters are still controver-
sial, the decision tree seems to be a more adequate
identification method. 
Which of both algorithms is the most adequate must
to be analysed further with more data. Perhaps it would
be necessary to study a group of elderly in which B
12
deficiency is not so highly prevalent. But in the mean-
time, using one of the algorithms seems to be more
adequate than analysing data separately.
The AUCs obtained for Scbl and HoloTC in our study
were somewhat different to those obtained by other
research teams.17,26,28 This difference may be attributable
to different definitions of vitamin B
12
used in these
studies, where individuals are categorized as having
likely vitamin B
12
deficiency based on MMA and tHcy
concentrations. The advantage of our study is that we
used a full set of clinical diagnostic criteria (biochemical,
haematological and morphological) to categorize indi-
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